Neuralace

ABOUT AXON THERAPY mPNS®

Rethink the Possibilities
of Neuromodulation

Rethink the Possibilities of Neuromodulation

A Revolutionary Approach to Treating Chronic Neuropathic Pain

With its breakthrough magnetic frequency, waveform, and algorithm, Axon Therapy mPNS represents the first 100% non-invasive electroceutical platform to deliver the clinical benefits of neuromodulation.

With its breakthrough magnetic frequency, waveform, and algorithm, Axon Therapy mPNS represents the first 100% non-invasive electroceutical

platform to deliver the clinical benefits of neuromodulation.

THE ADVANTAGES OF AXON THERAPY mPNS

What If You Could
Rewrite Pain for Millions?

What If You Could Rewrite Pain for Millions?

An average of 87% Reduction in Chronic Neuropathic Pain 1

Using magnetic pulses, Axon Therapy mPNS engages sensory, pain, and motor fibers mechanistically to recondition the Central Nervous System2 by eliminating noxious pain signals to the brain, reducing chronic neuropathic pain for respondent patients by up to 87%.

1 In respondent patients, VA Augusta Clinical Equipment Evaluation (CEC)
2 https://pubmed.ncbi.nlm.nih.gov/33737830/

Quality of Life Improvements from the First Treatment

After only one treatment, respondent patients report a 54% decrease in pain on average3, and a 72% average decrease after three treatments.4

3 VA Augusta Clinical Equipment Evaluation (CEC)
4 In Respondent Patients, VA Augusta Clinical Equipment Evaluation (CEC)
The Magnetic Approach to Neuromodulation

By contrast to conventional PNS, Axon Therapy uses low-frequency magnetic pulses to engage sensory, pain, and motor fibers mechanistically, providing long-term relief for the root cause of post-trauma and post-surgical neuropathic pain.

Finally, A Viable Alternative to Opioids

Axon Therapy mPNS represents a breakthrough for chronic neuropathic pain management that can minimize dependence on opioids and other medications with potentially adverse side effects by an average of 51%.4 Thanks to its exceptional efficacy and long-term results, mPNS can mitigate the risk of addiction and overdose while still providing substantial pain relief.

4 Bedder M, Parker L. Magnetic Peripheral Nerve Stimulation (mPNS) for Chronic Pain. J Pain Res. 2023;16:2365-2373

Recruiting Larger Fields of the Peripheral Nerve Bundle

With its low frequency (0-5 Hz), unique pulse width, and proprietary treatment algorithm, mPNS delivers high-intensity magnetic stimulation that induces larger fields than PNS across the nerve bundle in the periphery. This restores A-Beta functionality, and closes the door on chronic neuropathic pain.  

The Ideal Therapy for Pain Clinics

No other medical technology platform combines the same low frequency (0-5 Hz), unique pulse width, and proprietary treatment algorithm into a wheelable, plug-in 2’x2’ form factor. Making Axon Therapy mPNS the perfect technology platform for pain clinics to provide non-invasive neuromodulation.

 
CLINICAL DATA COMPARISON

The Unparalleled
Advantages of Axon
Therapy mPNS

The Unparalleled Advantages of Axon Therapy mPNS

Loading..........

The Data is Not Available

The Procedure

Conventional PNS / SCS

Small electrical leads implanted near peripheral nerves

Axon Therapy mPNS

100% non-invasive spot treatment with painless magnetic pulses near peripheral nerves

Nerve Recruitment

Conventional PNS / SCS

Shallow electric field with limited nerve recruitment

Axon Therapy mPNS

Maximal nerve recruitment with magnetic field

Avg. Annual Cost Per Patient

Conventional PNS / SCS

$9,000-$25,000

+Physician and Facility Fees

Axon Therapy mPNS

$6,300

*All in Cost

The Protocol

Conventional PNS / SCS

Treatment/Temporary trial sometimes followed by permanent implant

Axon Therapy mPNS

Multiple treatments month 1 followed by monthly treatments

Avg. Pain Responder Rate

Conventional PNS / SCS

57%

Axon Therapy mPNS

71%

*SEAT Trial

THE TECHNOLOGY WITHIN

In-Clinic, FDA-Cleared
Neuromodulation Technology

Neuralace Medical is the first to configure a high-intensity magnetic field into such a small physical footprint. The handheld coil that administers Axon Therapy treatments enables physicians to provide painless treatments in the clinic, not just in the OR.

It’s the only magnetic PNS device FDA-cleared for post-surgery and post-trauma neuromodulation, and with clinical trials already underway for urinary incontinence and painful diabetic neuropathy (PDN), we’re confident it will gain FDA clearance for even more indications.

Doctor Reviews

THE PROTOCOL

Improving Quality of Life 13.5 Minutes at a Time

Developed based on a full year of clinical research, the standard protocol for Axon Therapy mPNS has an average responder rate of >60% for neuropathic pain, and the treatment cycle couldn’t be simpler. It starts with 3 consecutive treatments in the first week, followed by weekly, bi-weekly, and monthly treatments.

Month 1

Week 1: 3 Treatments
Week 2-4: Weekly

Month 2

Month 2: Bi-Weekly

Month 3

Month 3 Onward: Monthly
ABOUT US

With Every Magnetic
Pulse, We’re Changing
Lives.

Meet the team using painless magnetic pulses to revolutionize chronic neuropathic pain management for patients and healthcare providers.

Add Axon Therapy mPNS to Your Clinic Today

Keith Warner

Chief Executive Officer

Proactive and engaging leader with expertise in advanced strategy development and implementation driving outstanding corporate growth. Over 25 years of senior level business acumen gained through key executive positions with leading large cap to venture stage startups within the life sciences and medical technology sectors. Experience in organization-building geared to achieve near and long term milestones both in domestic and international settings. Ability to deliver significant transformation and growth in financial performance, product development, investor fundraising, capital restructuring, P&L management, and strategic planning.